<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889744</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH0620160330</org_study_id>
    <nct_id>NCT02889744</nct_id>
  </id_info>
  <brief_title>Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest</brief_title>
  <official_title>Comparison of Cerebral Tissue Oxygen Saturation (SctO2) Between 36℃ and 33℃ of Targeted Temperature Management (TTM) After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bard Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that

        1. if decrease in SctO2 level is caused by the degree of hypothermia, SctO2 level in the
           33-TH may be lower than that in the 36-TH group.

        2. if decrease in SctO2 level is not caused by the degree of hypothermia but caused by
           brain injury, SctO2 level may be associated with only the prognosis of cardiac arrest
           victims regardless of core temperatures.

      The primary objective of this study is to compare the 72-hour changes in SctO2 level between
      the 36-TH and 33-TH groups in cardiac arrest victims.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Subject Identification and Screening For each cohort, patients will be identified after
           acquisition of sustained return of spontaneous circulation (ROSC) (&gt; 30 minutes). If the
           patients meet inclusion/exclusion criteria, patients will be enrolled in the study. The
           investigators will obtain written informed consent from all of the patients or their
           representatives.

        2. Assignment of Subject Number A unique identification number will be given to study
           subjects in an attempt to de-identify their information. Subject numbers will be
           assigned in sequential order. The subject number will consist of four digits. The first
           two digits will designate the study site. The last two digits will designate the subject
           by number in sequential order (i.e., subject number 01 01 will be the first subject at
           site 1; 01 02 will be the second subject at site 1, etc.).

        3. Study Methods

             -  Randomization to 36-TH (core body temperature (BT) 36℃) or 33-TH (core BT 33℃)
                group will be performed by a web based randomization site (http://mrcc.snuh.org).

             -  Start target temperature management using external cooling device (Arctic Sun)
                within 1 hour post-ROSC.

             -  SctO2 monitoring starts within 1 hour post-ROSC and maintain for 72 hours.

             -  36-TH (core BT 36℃) or 33-TH (core BT 33℃) for 24 hours

             -  Rewarming 0.25℃/h in 33-TH group

             -  Core temperature &lt; 37.5℃ for 72 hours

           All patients will be treated per the postresuscitation care protocol. Target treatment
           will include

             -  Target: central venous pressure (CVP) (8 - 12 mmHg), mean arterial pressure (MAP)
                (&gt; 65 mmHg), central venous oxygen saturation (ScvO2) (&gt; 70%)

             -  Seizure control, shivering control as appropriate

             -  Coronary intervention as soon as possible if needed

             -  Infection control if indicated

             -  Other supportive care

           Monitoring data including

             -  CVP, MAP, ScvO2, lactate, neuron specific enolase (NSE), end-tidal carbon dioxide
                (EtCO2), input-output (I/O) balance

             -  Intermittent electroencephalography (EEG) monitoring (2 times/72 hours)

             -  Laboratory data including arterial blood gas analysis (ABGA), complete blood count
                (CBC), liver function test (LFT), electrolyte, blood urea nitrogen/creatinine
                (BUN/Cr), et al.

             -  SctO2

             -  Core (esophageal or bladder) temperature

        4. Data Collection

      Study data will be collected in the following manner:

      • All data will be collected on appropriate Case Report Forms.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The comparison of the 72-hour SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims</measure>
    <time_frame>72 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The comparison of the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups</measure>
    <time_frame>0, 24, and 72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of the severity scores between the 36-TH and 33-TH groups</measure>
    <time_frame>0, 24, and 72 hours</time_frame>
    <description>APACHE II score
Sequential Organ Failure Assessment (SOFA) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of the serum biomarker levels between the 36-TH and 33-TH groups</measure>
    <time_frame>0, 24, and 72 hours</time_frame>
    <description>Neuron specific enolase
Cytokines
Antioxidants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of the number of patients with survival discharge between the 36-TH and 33-TH groups</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of the 6-month cerebral performance scale (CPC) between the 36-TH and 33-TH groups</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication of therapeutic hypothermia</measure>
    <time_frame>72 hours</time_frame>
    <description>Bleeding requiring transfusion
Fatal arrhythmia requiring intervention
Electrolyte imbalance: newly developed abnormal values
Hyper/hypoglycemia
Sepsis/pneumonia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Heart Arrest</condition>
  <arm_group>
    <arm_group_label>36-TH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Core temperature 36℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>33-TH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Core temperature 33℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arctic Sun</intervention_name>
    <description>Targeted temperature management for 24 hours with core temperature 36℃ or 33℃</description>
    <arm_group_label>36-TH</arm_group_label>
    <arm_group_label>33-TH</arm_group_label>
    <other_name>External cooling device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Comatose patients successfully resuscitated from cardiac arrest

        Exclusion Criteria:

          -  &lt; 18 years old

          -  Definite non-cardiac cause arrest

          -  Contraindication to TH Active bleeding, coagulopathy, fatal arrhythmia, severe
             infectious condition

          -  Presence of advanced directives to withhold or withdraw life-sustaining treatment

          -  Expected survival &lt; 72 hours

          -  Underlying low CPC (≤ 3)

          -  No informed consent

          -  Follow-up loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gil Joon Suh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National Univerisity College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Woon Yong Kwon, MD, PhD</last_name>
    <phone>82-2-2072-0326</phone>
    <email>kwy711@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoon Sun Jung, MD</last_name>
    <phone>82-10-3260-6113</phone>
    <email>loctos00@hanmail.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Woon Yong Kwon, MD, PhD</last_name>
      <phone>82-2-2072-0326</phone>
      <email>kwy711@hanmail.net</email>
    </contact>
    <contact_backup>
      <last_name>Yoon Sun Jung, MD</last_name>
      <phone>82-2-2262-4808</phone>
      <email>loctos00@hanmail.net</email>
    </contact_backup>
    <investigator>
      <last_name>Yoon Sun Jung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Woon Yong Kwon, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gil Joon Suh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyung Su Kim, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56. Erratum in: N Engl J Med 2002 May 30;346(22):1756.</citation>
    <PMID>11856793</PMID>
  </reference>
  <reference>
    <citation>Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Åneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Køber L, Langørgen J, Lilja G, Møller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17.</citation>
    <PMID>24237006</PMID>
  </reference>
  <results_reference>
    <citation>Buunk G, van der Hoeven JG, Meinders AE. A comparison of near-infrared spectroscopy and jugular bulb oximetry in comatose patients resuscitated from a cardiac arrest. Anaesthesia. 1998 Jan;53(1):13-9.</citation>
    <PMID>9505736</PMID>
  </results_reference>
  <results_reference>
    <citation>Suffoletto B, Kristan J, Rittenberger JC, Guyette F, Hostler D, Callaway C. Near-infrared spectroscopy in post-cardiac arrest patients undergoing therapeutic hypothermia. Resuscitation. 2012 Aug;83(8):986-90. doi: 10.1016/j.resuscitation.2012.03.021. Epub 2012 Apr 19.</citation>
    <PMID>22521725</PMID>
  </results_reference>
  <results_reference>
    <citation>Meex I, Dens J, Jans F, Boer W, Vanhengel K, Vundelinckx G, Heylen R, De Deyne C. Cerebral tissue oxygen saturation during therapeutic hypothermia in post-cardiac arrest patients. Resuscitation. 2013 Jun;84(6):788-93. doi: 10.1016/j.resuscitation.2013.01.003. Epub 2013 Jan 8.</citation>
    <PMID>23313422</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>September 21, 2017</last_update_submitted>
  <last_update_submitted_qc>September 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Temperature</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Brain</keyword>
  <keyword>Oxygen</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

